Filed: 11/14/2023ACC: 0001964437-23-000007
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $238.93M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
20
Positions
$238.93M
Total AUM (reported)
13.89M
Total Shares
Allocation by class
COM$196.01M82.0%
SPONSORED ADR$15.48M6.5%
COM NEW$14.59M6.1%
SHS$12.85M5.4%
Portfolio Concentration
Top 3$68.25M28.6%
4–10$103.13M43.2%
11–25$67.55M28.3%
Top 3 weight
28.6%
Top 10 weight
71.7%
Voting Authority Distribution
Total shares with voting rights: 13.89M
Sole
Full voting authority
13.89M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole20
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings20
Rows:
CRINETICS PHARMACEUTICALS IN
SOLEShares1.13M
TypeSH
Market value$33.50M
14.02%
Sole
1.13M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.81M
TypeSH
Market value$17.43M
7.30%
Sole
1.81M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.78M
TypeSH
Market value$17.31M
7.25%
Sole
1.78M
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.12M
TypeSH
Market value$16.77M
7.02%
Sole
1.12M
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares64.68K
TypeSH
Market value$16.62M
6.96%
Sole
64.68K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares886.14K
TypeSH
Market value$16.23M
6.79%
Sole
886.14K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares495.17K
TypeSH
Market value$14.59M
6.11%
Sole
495.17K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares118.40K
TypeSH
Market value$14.35M
6.01%
Sole
118.40K
Shared
0.00
None
0.00
HORIZON THERAPEUTICS PUB L
SOLEShares111.05K
TypeSH
Market value$12.85M
5.38%
Sole
111.05K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares807.97K
TypeSH
Market value$11.73M
4.91%
Sole
807.97K
Shared
0.00
None
0.00
ITEOS THERAPEUTICS INC
SOLEShares994.76K
TypeSH
Market value$10.89M
4.56%
Sole
994.76K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares112.47K
TypeSH
Market value$10.53M
4.41%
Sole
112.47K
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares577.10K
TypeSH
Market value$10.36M
4.34%
Sole
577.10K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares109.69K
TypeSH
Market value$9.70M
4.06%
Sole
109.69K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares1.22M
TypeSH
Market value$9.09M
3.81%
Sole
1.22M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares982.46K
TypeSH
Market value$6.96M
2.91%
Sole
982.46K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares10.07K
TypeSH
Market value$4.95M
2.07%
Sole
10.07K
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares136.74K
TypeSH
Market value$3.13M
1.31%
Sole
136.74K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares1.39M
TypeSH
Market value$970.9K
0.41%
Sole
1.39M
Shared
0.00
None
0.00
MERUS N V
SOLEShares40.07K
TypeSH
Market value$944.8K
0.40%
Sole
40.07K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CRINETICS PHARMACEUTICALS INSOLE | COM | 1.13M | SH | $33.50M 14.02% | 1.13M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.81M | SH | $17.43M 7.30% | 1.81M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.78M | SH | $17.31M 7.25% | 1.78M | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 1.12M | SH | $16.77M 7.02% | 1.12M | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 64.68K | SH | $16.62M 6.96% | 64.68K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 886.14K | SH | $16.23M 6.79% | 886.14K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 495.17K | SH | $14.59M 6.11% | 495.17K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 118.40K | SH | $14.35M 6.01% | 118.40K | 0.00 | 0.00 |
HORIZON THERAPEUTICS PUB LSOLE | SHS | 111.05K | SH | $12.85M 5.38% | 111.05K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 807.97K | SH | $11.73M 4.91% | 807.97K | 0.00 | 0.00 |
ITEOS THERAPEUTICS INCSOLE | COM | 994.76K | SH | $10.89M 4.56% | 994.76K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 112.47K | SH | $10.53M 4.41% | 112.47K | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 577.10K | SH | $10.36M 4.34% | 577.10K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 109.69K | SH | $9.70M 4.06% | 109.69K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 1.22M | SH | $9.09M 3.81% | 1.22M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 982.46K | SH | $6.96M 2.91% | 982.46K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 10.07K | SH | $4.95M 2.07% | 10.07K | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 136.74K | SH | $3.13M 1.31% | 136.74K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM | 1.39M | SH | $970.9K 0.41% | 1.39M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 40.07K | SH | $944.8K 0.40% | 40.07K | 0.00 | 0.00 |